ENDORSE · 109MS303
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, dose-blinded extension study to determine the long-term safety and efficacy of two doses of BG00012 as monotherapy in patients with relapsing-remitting multiple sclerosis. EudraCT: 2008-004753-14.
Sponsor: BIOGEN
Phase: III
Area: Neuroimmunology